NCT01854944View on ClinicalTrials.gov

PET Trial to Assess the Receptor Occupancy of Brexpiprazole in Adult Subjects With Schizophrenia

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

August 31, 2014

Conditions
Schizophrenia
Interventions
DRUG

Brexpiprazole 1mg to 4mg

Trial Locations (1)

10032

Columbia University, New York

All Listed Sponsors
lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY

NCT01854944 - PET Trial to Assess the Receptor Occupancy of Brexpiprazole in Adult Subjects With Schizophrenia | Biotech Hunter | Biotech Hunter